Mast Therapeutics, Inc. (NYSEMKT:MSTX)
CAPS Rating:
A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.
A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.
Recs
ripe for some nice upside now